Inovio Pharmaceuticals (INO) Competitors

Alpha Tau Medical (NASDAQ:DRTS) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Do analysts prefer DRTS or INO?

Alpha Tau Medical currently has a consensus target price of $8.00, suggesting a potential upside of 178.75%. Inovio Pharmaceuticals has a consensus target price of $12.40, suggesting a potential upside of 458.56%. Given Inovio Pharmaceuticals' higher probable upside, analysts clearly believe Inovio Pharmaceuticals is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inovio Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Do institutionals & insiders have more ownership in DRTS or INO?

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 2.5% of Inovio Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has more risk and volatility, DRTS or INO?

Alpha Tau Medical has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500.

Does the MarketBeat Community favor DRTS or INO?

Inovio Pharmaceuticals received 701 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 71.15% of users gave Inovio Pharmaceuticals an outperform vote while only 70.37% of users gave Alpha Tau Medical an outperform vote.

Company	Underperform	Outperform
Alpha Tau Medical	Outperform Votes 19 70.37%	Underperform Votes 8 29.63%
Inovio Pharmaceuticals	Outperform Votes 720 71.15%	Underperform Votes 292 28.85%

Is DRTS or INO more profitable?

Alpha Tau Medical's return on equity of -38.62% beat Inovio Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-38.62%	-29.89%
Inovio Pharmaceuticals	N/A	-118.17%	-83.47%

Does the media favor DRTS or INO?

In the previous week, Inovio Pharmaceuticals had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 2 mentions for Inovio Pharmaceuticals and 1 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.35 beat Inovio Pharmaceuticals' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Tau Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inovio Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable earnings & valuation, DRTS or INO?

Alpha Tau Medical has higher earnings, but lower revenue than Inovio Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$29.16M	-$0.43	-6.67
Inovio Pharmaceuticals	$830K	69.81	-$135.12M	N/A	N/A

Summary

Inovio Pharmaceuticals beats Alpha Tau Medical on 8 of the 14 factors compared between the two stocks.